WELCOME TO SENTINEL PLUS
This medical education website has been funded by AstraZeneca and co-developed with Hull University Teaching Hospitals NHS Trust. This website is intended for UK healthcare professionals only.
IMPLEMENTATION
SUPPORT
If you are interested in implementing the SENTINEL Plus quality improvement framework in your region – or have already started – and you would like further information or support from the SENTINEL team, please get in touch. See our enquiries form for areas of possible support.
ENQUIRY
FORM
Thank you. We will be in touch
GB-76226 | May 2026
SENTINEL Plus is developed with the aim of improving outcomes for asthma patients through identifying and addressing short-acting beta 2 agonist (SABA) over-reliance
GB-76210 | May 2026